Baroda BNP Paribas Health and Wellness Fund Direct Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 10.6848 ↓ -0.19%
[as on 1 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth and its peers as on 1 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Baroda BNP Paribas Health and Wellness Fund Direct Growth 12.03% -0.19% -3.3% -2.94% 2.62% 11.88%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -12.49% -1.3% -3.53% -6.07% -7.61% -12.86% 4.04% 10.56% 14% 13.47%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -8.41% -0.51% -2.15% -6.2% -4.8% -4.64% 7.63% 7.46% 11.9% 11.24%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 20.71% -0.29% -3.55% -3.34% 2.86% 20.19% 22.83% 17.78% 26.13% 14.6%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -2.81% -1% -2.42% -3.71% -6.43% 0.48% 11.75% 15.13% 18.63% 15.01%
SBI COMMA Fund - DIRECT PLAN - Growth 2.08% -1.4% -3.17% -5.11% -1.39% 7.79% 14.04% 9.74% 18.44% 14.92%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns----------

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.32% -4.12% 5.62% -4.75% 4.35% 3.91% 4.85% 5.43% 1.33% -2.75%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.78% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.22%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology9.01%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.01%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology7.99%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology6.23%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology5.99%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology5.66%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.44%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services4.50%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology3.56%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology3.42%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services3.24%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.10%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.05%
Max Financial Services LimitedMFSL (INE180A01020)Insurance2.43%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology2.38%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.29%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology2.24%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services2.23%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology2.15%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology2.14%
Metropolis Healthcare LimitedMETROPOLIS (INE112L01020)Healthcare Services1.49%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.49%
Nephrocare Health Services LtdNEPHROPLUS (INE428V01029)Healthcare Services1.35%
Manipal Health Enterprises Ltd (INE459N01021)Healthcare Services1.27%
Symbiotec Pharmalab Limited (INE899I01028)Pharmaceuticals & Biotechnology1.18%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology1.14%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.14%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology1.11%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing0.93%
Inventurus Knowledge Solutions LimitedIKS (INE115Q01022)IT - Services0.85%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.72%
Procter & Gamble Health LimitedPGHL (INE199A01012)Pharmaceuticals & Biotechnology0.57%
Life Insurance Corporation Of IndiaLICI (INE0J1Y01017)Insurance0.48%
Portfolio data is as on date 31 August, 2026

NAV history

Baroda BNP Paribas Health and Wellness Fund Direct Growth - 30 days NAV (Net asset value) history

DateNAV% change
1 October, 202610.6848 -0.19%
30 September, 202610.7052 -1.84%
29 September, 202610.9063 0.3%
28 September, 202610.8739 -1.15%
25 September, 202611.0002 -0.45%
24 September, 202611.0496 -0.86%
23 September, 202611.1452 0.58%
22 September, 202611.0813 -0.52%
21 September, 202611.1395 1.02%
18 September, 202611.0275 0.86%
17 September, 202610.9334 1.24%
16 September, 202610.7992 -0.14%
15 September, 202610.8138 -1.4%
11 September, 202610.9672 -0.1%
10 September, 202610.9777 -0.19%
9 September, 202610.9986 -0.31%
8 September, 202611.0323 0.63%
7 September, 202610.9630 0.61%
4 September, 202610.8970 -0.66%
3 September, 202610.9698 -0.05%
2 September, 202610.9750 -0.3%
1 September, 202611.0082 -1.03%
31 August, 202611.1230 0.25%
28 August, 202611.0948 0.33%
27 August, 202611.0586 0.41%
26 August, 202611.0132 0.34%
25 August, 202610.9764 0.99%
24 August, 202610.8684 -0.18%
21 August, 202610.8878 -0.25%
20 August, 202610.9146

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
    The latest NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth is 10.6848 as on 1 October, 2026.
  • What are YTD (year to date) returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
    The YTD (year to date) returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth are 12.03% as on 1 October, 2026.
  • What are 1 year returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
    The 1 year returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth are 11.88% as on 1 October, 2026.
  • What are top 10 holdings of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
    Top 10 holdings of Baroda BNP Paribas Health and Wellness Fund Direct Growth are:
    • Sun Pharmaceutical Industries Limited
    • Divi's Laboratories Limited
    • Torrent Pharmaceuticals Limited
    • IPCA Laboratories Limited
    • Lupin Limited
    • Laurus Labs Limited
    • Apollo Hospitals Enterprise Limited
    • Fortis Healthcare Limited
    • AstraZeneca Pharma India Limited
    • Glenmark Pharmaceuticals Limited
    • Dr. Lal Path Labs Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Baroda BNP Paribas Health and Wellness Fund Direct Growth?
    Baroda BNP Paribas Health and Wellness Fund Direct Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.